Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease

Published:2024-02 Issue: Volume:143 Page:106980
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Xia Jucheng,Dong Shuanghong,Yang Lili,Wang Fang,Xing Siqi,Du Jiyu,Li Zeng^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference68 articles.

1. Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor;Li;J. Med. Chem.,2020

2. Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease;Chen;Eur. J. Med. Chem.,2023

3. Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges;Zipfel;J. Med. Chem.,2020

4. Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress;Sang;Eur. J. Med. Chem.,2022

5. D'Ursi, New Aβ(1–42) ligands from anti-amyloid antibodies: Design, synthesis, and structural interaction;Santoro;Eur. J. Med. Chem.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents;Bioorganic & Medicinal Chemistry;2024-09

2. In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease;Drug Development Research;2024-04-18

3. Design of vilazodone-donepezil chimeric derivatives as acetylcholinesterase inhibitors by QSAR, molecular docking and molecular dynamics simulations;Physical Chemistry Chemical Physics;2024